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A. schaalii is a rare uropathogen. We report urosepsis with Actinobaculum schaalii detected serendipitously in blood and urine cul-
ture in a 79-year-old with urinary tract obstruction. This paper illuminates the ﬂaws in our current system in detecting A. schaalii
and raises awareness among clinicians and laboratory teams.
1.Introduction
Actinobaculum schaalii is a small Gram-positive coccoid rod
that requires CO2 for optimal growth. Also in the genus Acti-
nobaculum are A. suis, A. urinale,a n dA. massiliense. A. suis is
knowntocauseurinarytractinfections(UTIs)inswine[1,2]
and human UTIs have been reported with A. urinale and
A. massiliense [3–5]. A. schaalii, which is the focus of this
paper, was ﬁrst described as a cause of human UTIs in 1997,
with subsequent reports [6–8]. Growing evidence suggests
that A. schaalii may be a more common uropathogen in
the elderly than previously reported, especially those with
obstructive uropathy [7–13].
Most laboratories incubate urine cultures at 35◦Ci n
ambient air. Since A. schaalii grows slowly in aerobic con-
ditions with no CO2 supplementation, this bacterium’s iso-
lation and identiﬁcation from urine specimens by standard
laboratory methods is rare. Most laboratories do not look
speciﬁcally for Actinobaculum species. Even if A. schaalii
grows, this organism may be overlooked either because of
overgrowth of common uropathogens or the bacteria’s res-
emblance to normal skin ﬂora [7, 8, 11].
To address this problem, Bank et al. developed a TaqMan
real-time quantitative PCR and assessed 252 clinical urine
samples [9]. They found 22% of urine samples were positive
for A. schaalii in the over 60-year-old patient population,
whilst only 7% of samples were positive in the less than 60-
year-oldcohort[9].Usingthesamediagnostictechniqueina
cohort of patients with kidney stones, they showed that more
than24%ofurinesampleswerepositiveforA.schaalii,which
was the only pathogen in more than 60% of those patients
[13].
2.CaseReport
A 79-year-old man with a previous history of nephrolithiasis
and benign prostatic hyperplasia was admitted with fever,
chills, nausea, vomiting, and diarrhea. On presentation,
he had an elevated leukocyte count of 17.2 × 103 cells/µL
(90% neutrophils) and an elevated creatinine and lactate
(155µmol/L and 2.6mmol/L, resp.). His initial urinalysis
testedpositiveforbloodandleukocytes.Anultrasoundofthe
left kidney showed left hydronephrosis and an obstructing
stoneintheleftureter. Empiric parenteraltherapywithpipe-
racillin-tazobactam was initiated and subsequently a left
nephrostomy tube was placed. However, his condition dete-
riorated and the patient was transferred to the intensive care
unit (ICU). A repeat urinalysis revealed 4+ polymorphonu-
clear cells, 4+ Gram-positive bacilli and was negative for nit-
rate. The initial urine culture was negative; however, an
astute laboratory technologist noticed the discrepancy bet-
ween the Gram-stain and the culture results. In consulta-
tion with the microbiologist, the technologist repeated the
urine culture, including an anaerobic incubation. On repeat
culture, the patient’s urine culture grew 10 millionCFU/L
of a possible anaerobic Gram-positive bacillus with the
blood culture also growing anaerobic Gram-positive bacilli.2 Case Reports in Urology
Due to the unusual nature of the cultures in this urosepsis
patient, the samples were sent to the reference laboratory for
microorganism identiﬁcation. A. schaalii was identiﬁed from
blood culture. Although the care providers were informed
upon initial Gram-positive bacilli observation on smear, the
ﬁnal bacterial identiﬁcation result was released 12 days after
specimen receipt. Fortunately, A. schaalii is usually sensi-
tive to pip-tazo and the patient became stable following a
short stay in ICU. Subsequently, the patient’s stone was
unsuccessfully treated with extracorporeal shock wave litho-
tripsy (ESWL) and later deﬁnitively treated with an urete-
roscopy and laser lithotripsy.
3. Discussion
A. schaalii is an emerging uropathogen mainly in elderly pa-
tients or patients with underlying urologic disease [7, 9, 13].
Although there are a few reports of nonurological infections
[14, 15], the spectrum of infection primarily ranges from
benign cystitis to severe pyelonephritis with urosepsis.
A.schaaliihasbeenreportedinbothinpatientandoutpatient
populations,eitherasanisolatedorganismorassociatedwith
other common uropathogens [8–11, 13]. Unfortunately, our
routine laboratory methods will not identify A. schaalii from
urinespecimensasthisbacteriumrequiresCO2 andhasslug-
gish growth in comparison to common uropathogens. For
this reason, A. schaalii is identiﬁed from the blood rather
than from the urine in 30% of identiﬁed cases [11].
Urologists are recommended to notify the laboratory if
they are concerned about urinary infection with an unusual
organismsuchasA.schaalii,basedonriskfactorsorconﬂict-
ing laboratory results. Accordingly, conventional laboratory
methods must be modiﬁed to isolate A. schaalii from spec-
imens upon such requests. In addition, laboratories should
also consider A. schaalii as an etiology for UTI once there is
no growth from the urine specimen, despite the presence of
Gram-positive coccoid rods and/or leukocytes present on the
urinalysis.
Another important issue relates to the susceptibility pro-
ﬁle of A. schaalii is that it retains susceptibility to penicil-
lins, 3rd generation cephalosporins, aminoglycosides, and
nitrofurantoin. However, this organism is mainly resistant to
ciproﬂoxacin and trimethoprim/sulfamethoxazole [11, 12],
two commonly employed antibiotics in urology patients. To
our knowledge, all of the A. schaalii reports and studies have
been carried out in Europe with the exception of a single case
reportfromNorthAmerica[16].Therefore,mostofourclin-
iciansarenotawareofthispotentialuropathogen.Webelieve
that a well-designed multicenter study is required to ﬁnd out
the prevalence and incidence of A. schaalii.
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